RedHill Biopharma (RDHL) Gross Margin Growth (3y) (2017 - 2023)

RedHill Biopharma (RDHL) Gross Margin Growth (3y) (2017 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 631.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 106.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -675.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 7,053.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 33.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -344.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -37,361.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -1,517.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 3,557.00
10 RedHill Biopharma 119.32 Mn 119.32 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 2,301.00
Mar 31, 2023 11,762.00
Dec 31, 2022 -1,762.00
Sep 30, 2022 -895.00
Jun 30, 2022 -2,184.00
Mar 31, 2022 -2,402.00
Dec 31, 2021 -4,463.00
Sep 30, 2021 -1,560.00
Jun 30, 2021 -1,840.00
Mar 31, 2021 -1,180.00
Dec 31, 2020 -371.00
Sep 30, 2020 1,203.00
Jun 30, 2020 -1,157.00
Dec 31, 2017 -4,593.00
Sep 30, 2017 -6,139.00
Jun 30, 2017 -5,631.00